Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Release
  • Investors
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Our Culture
  • Press shift tab to select search category

    Loading...
  • Global Australia
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Foundation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Therapeutic Areas
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patients
  1. Home
  2. Company
  3. Leadership
  4. Tim Dow

Tim Dow

Back
Tim Dow

Tim Dow

  • Regularly Affairs and Quality Director
  • Follow in LinkedIn

Tim holds a Bachelor of Applied Science in Chemistry from the University of Technology, Sydney (UTS).  He has worked in the pharmaceutical industry for more than 26 years predominantly in regulatory affairs roles.  Tim joined Ipsen in 2017 and during that time has overseen the Therapeutic Goods Administration (TGA) registration of 4 new products and 10 new indications. 

IPN price

€102.70

 €-1.00 (-0.96%)

  • Media
  • Investors
  • Careers
  • Annual Report
  • Contact us
  • Distribution

Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms and conditions
  • Cookie Policy
  • Privacy Policy

© Ipsen Pharma. All rights reserved - 2025 Date of preparation: April 2024 CRSC-AU-000016

You are now leaving the Ipsen Australia website. To continue, please click on Continue?

Continue